scholarly journals Long-Term Cost Utility Analysis Of Ideglira Versus Basal-Bolus Insulin Intensification Therapies In Patients With Type 2 Diabetes Inadequately Controlled On Basal Insulin In Spain

2016 ◽  
Vol 19 (3) ◽  
pp. A99
Author(s):  
M Prades ◽  
L Lizan ◽  
B Hunt ◽  
A Ramirez de Arellano
Keyword(s):  
Type 2 Diabetes ◽  
Basal Insulin ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Utility Analysis ◽  
Insulin Intensification ◽  
Bolus Insulin ◽  
Basal Bolus

Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US

2012 ◽  
Vol 15 (sup2) ◽  
pp. 6-13 ◽  
Author(s):  
Yevgeniy Samyshkin ◽  
Anne-Laure Guillermin ◽  
Jennie H. Best ◽  
Steven C. Brunell ◽  
Adam Lloyd
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Utility Analysis ◽  
The Us ◽  
Diabetes Patients

Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes

2006 ◽  
Vol 22 (5) ◽  
pp. 861-872 ◽  
Author(s):  
Andrew J. Palmer ◽  
Sean Dinneen ◽  
James R. Gavin III ◽  
Alastair Gray ◽  
William H. Herman ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Blood Glucose ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Utility Analysis ◽  
Self Monitoring

Switching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimens

2013 ◽  
Vol 60 (5) ◽  
pp. 249-253
Author(s):  
Irene Vinagre ◽  
Juan Sánchez-Hernández ◽  
José Luis Sánchez-Quesada ◽  
Miguel Ángel María ◽  
Alberto de Leiva ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Therapy ◽  
Bolus Insulin ◽  
Basal Bolus ◽  
Term Type ◽  
Diabetes Patients
Sign in / Sign up

Export Citation Format

Share Document